HEALTH● LOWAug 28 · Aug 28, 2026, 12:18 PM
Amgen, Astra post late-stage trial win for asthma drug Tezspire in swallowing disorder
Seeking Alpha Tech · global
Amgen and Astra have achieved a late-stage trial win for their asthma drug Tezspire in treating a swallowing disorder. This development indicates potential progress in medical treatment for the condition.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH42m agoWhat the latest medical report says about the footballer who suffered a cardiac arrest after being kicked in the chestClarínHEALTH54m agoSpain introduces paid menopause sick leave from December 2026EuroNews [en]HEALTH1h agoInitiative to strengthen perinatal mental healthcare to be piloted in T.N.’s Villupuram districtThe HinduHEALTH1h agoMalaysia’s halal chicken scandal exposes hygiene breaches at filthy plantSouth China Morning Post